Zobrazeno 1 - 10
of 1 323
pro vyhledávání: '"Gleason Grade"'
Autor:
Haidar Al Saffar, Alice Thomson, Jo‐Lynn S. Tan, Qiwei Wang, Emma Birch, Samantha Koschel, Elizabeth Medhurst, Dale Jobson, Sean Ong, Daniel A. Moon, Declan Murphy, Nathan Lawrentschuk
Publikováno v:
BJUI Compass, Vol 5, Iss 4, Pp 497-505 (2024)
Abstract Introduction and Objectives Patient‐centred (PC) and holistic care improves patient satisfaction and health outcomes. We sought to investigate the benefit of utilising a PC pathology report in patients undergoing radical prostatectomy (RP)
Externí odkaz:
https://doaj.org/article/fe12572287e445289fd9d026653fa71f
Publikováno v:
Measurement: Sensors, Vol 33, Iss , Pp 101128- (2024)
Prostate cancer, or PCa, is a prominent male malignancy. For men with prostate cancer, accurate staging is essential for planning treatment and determining the prognosis. The way prostate cancer is currently diagnosed has led to two types of problems
Externí odkaz:
https://doaj.org/article/2db327c0da984d1587976d5613f73486
Publikováno v:
Annals of Urologic Oncology, Vol 6, Iss 4, Pp 35-40 (2023)
Introduction Angiogenesis has been proposed as a promising prognostic marker in a variety of tumours. Microvessel density (MVD) measurement is the most reliable method for the semiquantitative evaluation of angiogenesis. Endoglin (CD105) is a recogni
Externí odkaz:
https://doaj.org/article/12543b6dc93f4aacb2acdaddeae61b04
Publikováno v:
Journal of Mazandaran University of Medical Sciences, Vol 33, Iss 2, Pp 316-322 (2023)
Background and purpose: Prostate cancer is the most prevalent non-cutaneous malignancy in men. The Gleason grading system is an important prognostic factor in prostatic carcinoma. Nowadays, identifying biomarkers indicating high-risk patients and tar
Externí odkaz:
https://doaj.org/article/4726dfa2e4504244ac82dd04079b4164
Publikováno v:
Journal of Mazandaran University of Medical Sciences, Vol 33, Iss 226, Pp 172-178 (2023)
Background and purpose: Prostate cancer is the second cause of cancer-related death in men. Early diagnosis and identification of prognostic factors help to predict clinical outcome and select the most effective treatment protocol in each patient. Th
Externí odkaz:
https://doaj.org/article/f892e67b9f5d4752adcc2062407b5b54
Autor:
Yashwanth Karthik Kumar Mamidi, Tarun Karthik Kumar Mamidi, Md Wasi Ul Kabir, Jiande Wu, Md Tamjidul Hoque, Chindo Hicks
Publikováno v:
Machine Learning and Knowledge Extraction, Vol 5, Iss 4, Pp 1302-1319 (2023)
A critical unmet medical need in prostate cancer (PCa) clinical management centers around distinguishing indolent from aggressive tumors. Traditionally, Gleason grading has been utilized for this purpose. However, tumor classification using Gleason G
Externí odkaz:
https://doaj.org/article/06b7dca811c24b80ac8f504a5026576b
Autor:
Natalia L. Acosta-Vega, Rodolfo Varela, Jorge Andrés Mesa, Jone Garai, Alberto Gómez-Gutiérrez, Silvia J. Serrano-Gómez, Jovanny Zabaleta, María Carolina Sanabria-Salas, Alba L. Combita
Publikováno v:
Frontiers in Oncology, Vol 14 (2024)
BackgroundAfrican ancestry is a known factor associated with the presentation and aggressiveness of prostate cancer (PC). Hispanic/Latino populations exhibit varying degrees of genetic admixture across Latin American countries, leading to diverse lev
Externí odkaz:
https://doaj.org/article/ac93b3caeb6a46279ba77085872f81cd
Autor:
Worapong Promsen, Satit Siriboonrid, Nattapong Binsri, Sarayut Kanjanatarayon, Weerayut Wiriyabanditkul, Vittaya Jiraanankul
Publikováno v:
Urology Annals, Vol 15, Iss 1, Pp 18-21 (2023)
Background: The risk stratification of prostate cancer using Gleason grade group (GG), serum prostate-specific antigen (PSA), and T staging has an important role for appropriate treatment. In fact, the GG of biopsy was not the same as the prostatecto
Externí odkaz:
https://doaj.org/article/48180a2f8f4a4f1689aa11be925c2f5f
Autor:
Terence Tang, Stephanie Gulstene, Eric McArthur, Andrew Warner, Gabriel Boldt, Vikram Velker, David D'Souza, Glenn Bauman, Lucas C. Mendez
Publikováno v:
Clinical and Translational Radiation Oncology, Vol 38, Iss , Pp 21-27 (2023)
Background: Localized Gleason Grade Group 5 (GG5) prostate cancer has a poor prognosis and is associated with a higher risk of treatment failure, metastases, and death. Treatment intensification with the addition of a brachytherapy (BT) boost to exte
Externí odkaz:
https://doaj.org/article/77cbd8265c2043d6ab6cdb6977ec0eb7
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.